Policy and Medicine (09/20/2019) Sullivan, Thomas
The CELink program offers an adaptive learning continuing medical education (CME) approach for clinicians to cope with the opioid epidemic through the American Board of Medical Specialties' Continuing Certification Directory. A new adaptive-learning CME activity from Rockpointe, "Opioid Analgesics: Risk Evaluation and Mitigation Strategy (REMS) and the New FDA Blueprint," provides users with a review of the Food and Drug Administration's updated educational blueprint to aid in the evidence-based management of their patients' pain, offering tools for clinicians to use in mitigating issues with opioid treatments. This program is designed for those participating in direct patient care, including Drug Enforcement Agency-registered clinicians who qualify to prescribe all opioid analgesics, in addition to members of the healthcare team who are not eligible to prescribe. CELink's adaptive-learning instructional design facilitates a personalized educational experience for each learner, incorporating text, interactive questions, and audio of faculty experts synced with a slide presentation. Based on the program's algorithm, participants with a good grasp of the concepts being taught can move forward, while less knowledgeable participants receive additional content/questions to help them better understand the topic at hand. CELink is planned and deployed in compliance with the accreditation mandates and policies of the Accreditation Council for Continuing Medical Education.